nifedipine has been researched along with glyceryl 2-arachidonate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Haj-Dahmane, S; Shen, RY | 1 |
Alger, BE; Gorzalka, BB; Hill, MN; Hillard, CJ; Wang, M; Zhang, L | 1 |
2 other study(ies) available for nifedipine and glyceryl 2-arachidonate
Article | Year |
---|---|
Regulation of plasticity of glutamate synapses by endocannabinoids and the cyclic-AMP/protein kinase A pathway in midbrain dopamine neurons.
Topics: Animals; Arachidonic Acids; Calcium Channel Blockers; Calcium Channels, L-Type; Cannabinoid Receptor Modulators; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dopamine; Endocannabinoids; Glutamic Acid; Glycerides; Long-Term Synaptic Depression; Male; Mesencephalon; Neuronal Plasticity; Neurons; Nifedipine; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, N-Methyl-D-Aspartate; Synapses; Synaptic Transmission; Type C Phospholipases; Ventral Tegmental Area | 2010 |
Acute restraint stress enhances hippocampal endocannabinoid function via glucocorticoid receptor activation.
Topics: Animals; Arachidonic Acids; CA1 Region, Hippocampal; Calcium; Calcium Channel Blockers; Calcium Channels; Cannabinoid Receptor Modulators; Corticosterone; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Endocannabinoids; gamma-Aminobutyric Acid; Glycerides; Inhibitory Postsynaptic Potentials; Male; Nifedipine; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Receptors, Muscarinic; Stress, Psychological | 2012 |